When tissue is severely damaged, surviving cells can respond in a concentrated burst of biological repair known as ...

US pharma major AbbVie and China’s RemeGen today announced an exclusive licensing agreement for the development, ...

A recent study links chemotherapy to impaired ovarian function and fertility through oxidative damage to ovarian follicles.

AbbVie (NYSE: ABBV) and RemeGen today announced an exclusive licensing agreement for the development, manufacturing and commercialization of RC148, a novel investigational Programmed Cell Death-1 ...

The deal is the second Chinese oncology pact in as many weeks for AbbVie, which also committed $175 million for a ...

Pancreatic cancer is notoriously hard to treat, often resisting therapies that target its most common mutations. Researchers ...

A diet high in fat is one of the strongest contributors to liver cancer risk. New research from MIT sheds light on why this ...

A new kind of microscope is giving scientists a way to watch life inside cells with a clarity that feels almost unfair.

AbbVie and RemeGen are the first companies to announce a deal at the J.P Morgan Healthcare Conference 2026, with more deals ...

Pancreatic ductal adenocarcinoma (PDAC) is the most lethal form of pancreas cancer. It's also the most common form of the ...

Chronic inflammation resulting from obesity is considered dangerous and leaves many confused about whether this actually ...

In a new study published in Liver Research, a team of researchers in China discovered that nicotinic acid-a common form of ...